Siemens Healthineers AG (ETR:SHL)
Germany · Delayed Price · Currency is EUR 39.59
+0.42 (1.07%)
Aug 11, 2026, 5:35 PM CET
Siemens Healthineers AG Income Statement
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 23,169 | 23,375 | 22,363 | 21,680 | 21,714 | 17,997 | |
Revenue Growth | -0.91% | 4.52% | 3.15% | -0.16% | 20.65% | 24.46% |
Cost of Revenue | 14,127 | 14,345 | 13,895 | 13,971 | 13,577 | 11,045 |
Gross Profit | 9,040 | 9,030 | 8,468 | 7,709 | 8,137 | 6,952 |
Selling, General & Admin | 3,871 | 3,887 | 3,681 | 3,607 | 3,408 | 2,817 |
Research & Development | 1,949 | 1,958 | 1,918 | 1,866 | 1,785 | 1,546 |
Other Operating Expenses | -14 | 31 | 62 | 100 | 18 | 16 |
Total Operating Expenses | 5,806 | 5,876 | 5,661 | 5,573 | 5,211 | 4,379 |
Operating Income | 3,230 | 3,154 | 2,807 | 2,135 | 2,927 | 2,573 |
Interest Income | 95 | 99 | 119 | 85 | 48 | 33 |
Interest Expense | -406 | -425 | -476 | -296 | -118 | -83 |
Other Non-Operating Income (Expense) | -23 | 25 | 74 | 4 | -57 | -120 |
Total Non-Operating Income (Expense) | -334 | -301 | -283 | -207 | -127 | -170 |
Pretax Income | 2,894 | 2,853 | 2,523 | 1,928 | 2,800 | 2,404 |
Provision for Income Taxes | 654 | 686 | 564 | 403 | 746 | 658 |
Net Income | 2,241 | 2,168 | 1,959 | 1,525 | 2,054 | 1,746 |
Minority Interest in Earnings | 27 | 23 | 17 | 16 | 17 | 18 |
Net Income to Common | 2,212 | 2,144 | 1,942 | 1,509 | 2,038 | 1,727 |
Net Income Growth | 1.84% | 10.40% | 28.69% | -25.96% | 18.01% | 22.39% |
Shares Outstanding (Basic) | 1,119 | 1,120 | 1,118 | 1,119 | 1,123 | 1,100 |
Shares Outstanding (Diluted) | 1,119 | 1,125 | 1,123 | 1,124 | 1,128 | 1,104 |
Shares Change | -0.55% | 0.11% | -0.01% | -0.37% | 2.19% | 9.91% |
EPS (Basic) | 1.98 | 1.91 | 1.74 | 1.35 | 1.81 | 1.57 |
EPS (Diluted) | 1.98 | 1.91 | 1.73 | 1.34 | 1.81 | 1.57 |
EPS Growth | 2.41% | 10.41% | 29.10% | -25.97% | 15.29% | 12.14% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Free Cash Flow | 3,422 | 3,532 | 2,826 | 2,119 | 2,504 | 2,933 |
Free Cash Flow Growth | -11.05% | 24.98% | 33.37% | -15.38% | -14.63% | 52.13% |
Free Cash Flow Per Share | 3.06 | 3.14 | 2.52 | 1.89 | 2.22 | 2.66 |
Dividends Per Share | - | 1.000 | 0.950 | 0.950 | 0.950 | 0.850 |
Dividend Growth | - | 5.26% | 0% | 0% | 11.77% | 6.25% |
Gross Margin | 39.02% | 38.63% | 37.87% | 35.56% | 37.47% | 38.63% |
Operating Margin | 13.94% | 13.49% | 12.55% | 9.85% | 13.48% | 14.30% |
Profit Margin | 9.67% | 9.27% | 8.76% | 7.03% | 9.46% | 9.70% |
FCF Margin | 14.77% | 15.11% | 12.64% | 9.77% | 11.53% | 16.30% |
EBITDA | 4,401 | 4,450 | 4,030 | 3,692 | 4,270 | 3,612 |
EBITDA Margin | 19.00% | 19.04% | 18.02% | 17.03% | 19.66% | 20.07% |
EBIT | 3,230 | 3,154 | 2,807 | 2,135 | 2,927 | 2,573 |
EBIT Margin | 13.94% | 13.49% | 12.55% | 9.85% | 13.48% | 14.30% |
Effective Tax Rate | 22.60% | 24.04% | 22.35% | 20.90% | 26.64% | 27.37% |